Search clinical trials for: Severe pneumonia

Total 17681 results

Apellis Pharmaceuticals, Inc.

Completed

A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Severe Acute Respiratory Syndrome | Coronavirus Infection | Covid-19 | COVID | Acute Respiratory Distress Syndrome | Coronavirus | Ards | Severe Acute Respiratory Syndrome Coronavirus 2 | Sars-CoV2

United States, Brazil
Dr. Reddy's Laboratories Limited

Terminated

Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients

Covid19

Kuwait
University of Sao Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Completed

Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection (HEPMAB)

Covid19

Brazil
The George Institute

Completed

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease (CLARITY)

COVID-19 | Coronavirus Disease 2019

Australia, India
BeiGene

Completed

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Covid19

United States, Mexico, Brazil, South Africa
Campus Bio-Medico University
National Institute of Environmental Health Sciences (NIEHS)

Completed

Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes (HA-COVID)

Covid19

Italy
The University of Queensland
Griffith University; The Prince Charles Hospital; Princess Alexandra Hospital... and other collaborators

Completed

Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85 (COVIDRASP)

Covid19 | Respiratory Viral Infection

Australia
William Beaumont Hospitals

Terminated

ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS) (ABACCuS)

Coronavirus Infections | COVID-19 | Severe Acute Respiratory Syndrome (SARS)

United States
Hospital Alemão Oswaldo Cruz
Hospital Israelita Albert Einstein; Hospital Moinhos de Vento; Hospital do Coracao and other collaborators

Completed

Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19) (COALITION-V)

COVID-19

Brazil
Federal Research Clinical Center of Federal Medical...

Completed

The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19 (COVID-VIT)

SARS-CoV2 Infection

Russian Federation
Applied Biology, Inc.

Withdrawn

Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Brazil
Applied Biology, Inc.

Withdrawn

Proxalutamide Treatment for COVID-19 Female Outpatients

Covid19 | SARS-CoV Infection

Brazil
Taipei City Hospital

Completed

Investigation on the Epidemic Prevention Effect of Using Chinese Medicine During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak.

COVID-19 Pandemic

Taiwan
Advocate Health Care

Completed

COVID-19 IgG Formation in Physicians at ALGH and Their Household Members

Covid19 | SARS-CoV Infection | Communicable Disease

United States
Hunter Holmes Mcguire Veteran Affairs Medical Center
McGuire Research Institute

Completed

Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation (AVoCaDO)

COVID-19 | Hypoxia

United States
NGM Biopharmaceuticals, Inc

Terminated

A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19

SARS-CoV-2 Infection

Australia
Scandinavian Critical Care Trials Group
Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaborators

Completed

Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia (COVIDSTEROID2)

Hypoxia | Covid19

Sweden, India, Denmark, Switzerland
Direction Centrale du Service de Santé des Armées

Active, not recruiting

Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions (COVID-TRUST)

Covid19 | Burnout, Professional | SARS-CoV Infection | Burnout, Caregiver

France
Institut Pasteur
Institut Pasteur de Nouvelle-Calédonie; Centre Hospitalier Territorial de Nouvelle-Calédonie and other collaborators

Completed

Household Transmission Investigation Study for COVID-19 in Tropical Regions (EPI-COVID-19)

Severe Acute Respiratory Syndrome | Coronavirus Infections | SARS-CoV Infection

French Guiana, Guadeloupe, New Caledonia
Institut Pasteur
Eurofins; Institut Pasteur de la Guyane; Laboratoire de biologie médicale, Institut... and other collaborators

Completed

COVID-19 Seroprevalence Study in French Guiana (EPI-COVID-POP)

Severe Acute Respiratory Syndrome | Coronavirus Infection | Covid19 | SARS-CoV Infection

French Guiana
International Centre for Diarrhoeal Disease Research...
University of Edinburgh; NIHR Global Health Research Unit on Respiratory Health... and other collaborators

Completed

Feasibility and Acceptability Followed by Effectiveness of bCPAP for Treatment of Bangladeshi Children With Severe Pneumonia (Child-bCPAP)

Feasibility

Bangladesh
Clinical Hospital Center, Split

Completed

Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2

Corona Virus Infection | Pneumonia, Ventilator-Associated

Croatia
Hoffmann-La Roche
Gilead Sciences

Completed

A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia (REMDACTA)

COVID-19 Pneumonia

United States, Spain, Brazil, Russian Federation
Toscana Life Sciences Sviluppo s.r.l.

Active, not recruiting

Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.

Covid19

Italy
National Institute of Respiratory Diseases, Mexico

Completed

Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) (PHYDRA)

Severe Acute Respiratory Syndrome | COVID-19

Mexico
ImmunityBio, Inc.

Active, not recruiting

Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation

COVID

United States
National Institute of Respiratory Diseases, Mexico

Completed

Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) (HYDRA)

Severe Acute Respiratory Syndrome | COVID-19

Mexico
Assistance Publique - Hôpitaux de Paris

Completed

RAPid SOlution for Diagnosis of Respiratory Infection in Pediatric Intensive Care Unit (RAPSODI)

Severe Infections Pneumonia With Invasive Ventilation in PICU

France
BeiGene

Completed

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants

Covid19

Australia
William Beaumont Hospitals

Terminated

Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 (SINK COVID-19)

Coronavirus Infections | COVID-19 | Acute Respiratory Distress Syndrome | Severe Acute Respiratory Syndrome (SARS)

United States
R-Pharm International, LLC
Data Management 365; K-Research, LLC

Completed

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

COVID-19

Russian Federation
Universidade de Passo Fundo

Completed

Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19

Microbial Colonization | Severe COVID-19 | COVID-19 Lower Respiratory Infection | Secondary Bacterial Pneumonia

Brazil
LCMC Health

Terminated

Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease (RCT)

COVID-19

United States
Denver Health and Hospital Authority
University of Colorado, Denver; University of Miami; Beth Israel Deaconess Medical... and other collaborators

Completed

Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection

Severe Acute Respiratory Syndrome | Respiratory Failure | Acute Respiratory Distress Syndrome

United States
Dompé Farmaceutici S.p.A

Completed

Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.

Pneumonia, Viral

United States, Italy
Groupe Hospitalier Paris Saint Joseph
Centre Hospitalier Victor Dupouy

Terminated

Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia (LPSARS2)

Covid19 | Community-acquired Pneumonia

France
CytoDyn, Inc.

Active, not recruiting

Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019

United States
Apogenix AG

Completed

Asunercept in Patients With Severe COVID-19 (ASUNCTIS)

Covid19 | COVID-19 Induced Pneumonia

Spain, Russian Federation
Evidation Health
Eli Lilly and Company; United States Department of Defense; Bill and Melinda... and other collaborators

Completed

A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections

Covid19 | SARS-CoV Infection

United States
Inova Health Care Services

Terminated

Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma (Inova-CCP)

Covid-19

United States
Genentech, Inc.
Biomedical Advanced Research and Development Authority

Completed

A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia (COVASTIL)

COVID-19 Pneumonia

United States, Spain, Brazil, Mexico
CES University

Terminated

Ivermectin in Adults With Severe COVID-19.

Severe Acute Respiratory Syndrome | Covid19

Colombia
Schön Klinik Berchtesgadener Land

Completed

Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19 (STEPCO)

Quality of Life | Covid19 | Pulmonary Rehabilitation | SARS-CoV Infection

Germany
Children's Hospital Medical Center, Cincinnati

Terminated

Serology to COVID-19 for Recording Exposures and Evaluating Needs (SCREEN)

Covid19 | SARS-CoV Infection | Coronavirus

United States
Postgraduate Institute of Medical Education and...

Completed

Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease (SHADE-S)

Covid19

India
University of Washington
Bill and Melinda Gates Foundation

Completed

Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)

COVID-19 | Corona Virus Infection | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)

United States
University of Washington
National Institute of Allergy and Infectious Diseases (NIAID); Fred Hutchinson...

Completed

Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study) (IICov19PRS)

COVID-19 | Coronavirus Infection | SARS-CoV-2 Infection | SARS (Severe Acute Respiratory Syndrome)

United States
Kinevant Sciences GmbH
Roivant Sciences, Inc.

Completed

A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)

COVID-19

United States
Applied Biology, Inc.

Completed

Anti-Androgen Treatment for COVID-19

COVID-19 | Benign Prostatic Hyperplasia | Prostate Cancer | SARS-CoV2 | Androgenetic Alopecia | SARS (Severe Acute Respiratory Syndrome)

Brazil
University of Baghdad

Completed

Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection

COVID-19 Pandemic

Iraq

Search clinical trials for: Severe pneumonia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations